Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 420 citing articles:

Advances in COVID-19 mRNA vaccine development
Enyue Fang, Xiaohui Liu, Miao Li, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 392
COVID-19 vaccine development: milestones, lessons and prospects
Maochen Li, Han Wang, Lili Tian, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 331
Covid‐19 vaccines and variants of concern: A review
Ikbel Hadj Hassine
Reviews in Medical Virology (2021) Vol. 32, Iss. 4
Open Access | Times Cited: 313
Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Ali Pormohammad, Mohammad Zarei, Saied Ghorbani, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 467-467
Open Access | Times Cited: 297
Efficacy and safety of COVID-19 vaccines
Carolina Graña, Lina Ghosn, Theodoros Evrenoglou, et al.
Cochrane library (2022) Vol. 2023, Iss. 3
Open Access | Times Cited: 251
Efficacy and Safety of the RBD-Dimer–Based Covid-19 Vaccine ZF2001 in Adults
Lianpan Dai, Lidong Gao, Lifeng Tao, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 22, pp. 2097-2111
Open Access | Times Cited: 222
Evaluation of the safety profile of COVID-19 vaccines: a rapid review
Qianhui Wu, Matthew Z. Dudley, Xinghui Chen, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 213
SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
Daniel Martínez-Flores, Jesús Zepeda–Cervantes, Adolfo Cruz-Reséndiz, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 211
The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach
Matthew Greenhawt, Elissa M. Abrams, Marcus Shaker, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 9, Iss. 10, pp. 3546-3567
Open Access | Times Cited: 193
The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges
Jonaid Ahmad Malik, Sakeel Ahmed, Mir Aroosa, et al.
Journal of Infection and Public Health (2022) Vol. 15, Iss. 2, pp. 228-240
Open Access | Times Cited: 173
Antibodies and Vaccines Target RBD of SARS-CoV-2
Long Min, Qiu Sun
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 154
Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines
Yunlong Cao, Ayijiang Yisimayi, Yali Bai, et al.
Cell Research (2021) Vol. 31, Iss. 7, pp. 732-741
Open Access | Times Cited: 153
Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates
Qian He, Qunying Mao, Chaoqiang An, et al.
Emerging Microbes & Infections (2021) Vol. 10, Iss. 1, pp. 629-637
Open Access | Times Cited: 142
COVID-19 Vaccines and the Skin
Qisi Sun, Ramie Fathy, Devon E. McMahon, et al.
Dermatologic Clinics (2021) Vol. 39, Iss. 4, pp. 653-673
Open Access | Times Cited: 142
Scientific rationale for developing potent RBD-based vaccines targeting COVID-19
Harry Kleanthous, Judith M. Silverman, Karen W. Makar, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 136
A Comprehensive Review of the Protein Subunit Vaccines Against COVID-19
Mohsen Heidary, Vahab Hassan Kaviar, Maryam Shirani, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 131
The impact of spike mutated variants of SARS-CoV2 [Alpha, Beta, Gamma, Delta, and Lambda] on the efficacy of subunit recombinant vaccines
Mehrdad Mohammadi, Mohammad Shayestehpour, Hamed Mirzaei
The Brazilian Journal of Infectious Diseases (2021) Vol. 25, Iss. 4, pp. 101606-101606
Open Access | Times Cited: 125
Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2
Kun Xu, Ping Gao, Sheng Liu, et al.
Cell (2022) Vol. 185, Iss. 13, pp. 2265-2278.e14
Open Access | Times Cited: 113
COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations
Qian He, Qunying Mao, Jialu Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 111
Immunogenicity of clinically relevant SARS-CoV-2 vaccines in nonhuman primates and humans
Per Johan Klasse, Douglas F. Nixon, John P. Moore
Science Advances (2021) Vol. 7, Iss. 12
Open Access | Times Cited: 110
Safety and Efficacy of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Different Vaccines at Phase 3
Yujing Fan, Kwok‐Hung Chan, Ivan Fan‐Ngai Hung
Vaccines (2021) Vol. 9, Iss. 9, pp. 989-989
Open Access | Times Cited: 109
Nasal vaccination against SARS-CoV-2: Synergistic or alternative to intramuscular vaccines?
Mattia Tiboni, Luca Casettari, Lisbeth Illum
International Journal of Pharmaceutics (2021) Vol. 603, pp. 120686-120686
Open Access | Times Cited: 104
Two Years into the COVID-19 Pandemic: Lessons Learned
Severino Jefferson Ribeiro da Silva, Jéssica Catarine Frutuoso do Nascimento, Renata Pessôa Germano Mendes, et al.
ACS Infectious Diseases (2022) Vol. 8, Iss. 9, pp. 1758-1814
Open Access | Times Cited: 103
A comprehensive review on COVID-19 vaccines: development, effectiveness, adverse effects, distribution and challenges
Md. Mijanur Rahman, Md. Habib Ullah Masum, Shah Wajed, et al.
VirusDisease (2022) Vol. 33, Iss. 1, pp. 1-22
Open Access | Times Cited: 98
An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice
Etsuro Nanishi, Francesco Borriello, Timothy R. O’Meara, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 629
Open Access | Times Cited: 87
Page 1 - Next Page

Scroll to top